Żabińska, M.; Gaffke, L.; Bielańska, P.; Podlacha, M.; Rintz, E.; Cyske, Z.; Węgrzyn, G.; Pierzynowska, K.
Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach. Pharmaceutics 2023, 15, 704.
https://doi.org/10.3390/pharmaceutics15020704
AMA Style
Żabińska M, Gaffke L, Bielańska P, Podlacha M, Rintz E, Cyske Z, Węgrzyn G, Pierzynowska K.
Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach. Pharmaceutics. 2023; 15(2):704.
https://doi.org/10.3390/pharmaceutics15020704
Chicago/Turabian Style
Żabińska, Magdalena, Lidia Gaffke, Patrycja Bielańska, Magdalena Podlacha, Estera Rintz, Zuzanna Cyske, Grzegorz Węgrzyn, and Karolina Pierzynowska.
2023. "Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach" Pharmaceutics 15, no. 2: 704.
https://doi.org/10.3390/pharmaceutics15020704
APA Style
Żabińska, M., Gaffke, L., Bielańska, P., Podlacha, M., Rintz, E., Cyske, Z., Węgrzyn, G., & Pierzynowska, K.
(2023). Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach. Pharmaceutics, 15(2), 704.
https://doi.org/10.3390/pharmaceutics15020704
